Bone & Aging Health

Advanced screening panel evaluating hormonal and microscopic markers of bone remodeling to assess bone density trajectory and aging-related bone loss.

CHF599.00
35 Biomarkers
0 Health Domains
48h Results
ISO 15189 Certified
Bone & Aging Health

What This Measures

PTH (Parathyroid Hormone)

Measures the primary hormone responsible for regulating calcium and phosphorus levels in the blood, critical for healthy bone remodeling and prevention of excessive bone loss.

Bone Turnover Markers (CTX and P1NP)

Evaluates real-time rates of bone breakdown (CTX) and bone formation (P1NP), providing a dynamic picture of skeletal health.

Why It's Important

  • Bone loss is silent and accelerates with age, often unnoticed until fracture or advanced osteoporosis appears.
  • This panel helps identify hidden imbalances between bone formation and bone breakdown.
  • It can detect early signs of accelerated age-related bone loss.
  • It can reveal biological drivers of osteopenia or osteoporosis.
  • It can highlight calcium utilization issues mediated by PTH.
  • It provides insight into dynamic risk for future skeletal fragility.

Potential Benefits

  • Earlier awareness of silent, accelerated bone breakdown.
  • Opportunity for targeted nutritional, lifestyle, and load-bearing exercise interventions.
  • Supports long-term skeletal strength, mobility, and healthy physical aging.
  • Helps guide and monitor bone-preserving treatments.
  • Peace of mind through advanced visibility into functional bone health.

Who May Benefit Most

  • Individuals with a family history of osteoporosis, osteopenia, or frequent fractures.
  • People approaching or in menopause when bone loss accelerates.
  • Those monitoring skeletal health alongside longevity goals.
  • Individuals with vitamin D deficiency, calcium imbalance, or malabsorption issues.
  • Anyone seeking deeper reassurance beyond a standard bone density scan.

Important to Know

  • This is a real-time metabolic assessment of bone turnover, not a replacement for a DEXA bone density scan.
  • Bone marker levels fluctuate; results are best interpreted alongside calcium, vitamin D, and clinical context.
  • Abnormalities can help personalize prevention or treatment to preserve bone mass.

Conditions Addressed:

Imbalance between bone formation and bone breakdown
Accelerated age-related bone loss
Osteopenia or osteoporosis risk drivers
Calcium utilization issues mediated by PTH
Dynamic risk for future skeletal fragility
CHF599.00